glp-1 with alcohol alcoholism Possible mechanisms by which may reduce consumption. (A) GLP-1 Medications and Alcohol: A – GLP-1s Hold Promise as Treatment

Zayed MY-C, Kim B-H, Jeong

Individual variation and plotter limitations Every plotter uses population-average pharmacokinetic parameters

David Munoz, MD., FRCP (St

The peptides role in extracellular matrix remodelling and its ability to support proper inflammatory resolution make it of interest to researchers examining tissue regeneration in various contexts

When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities

Metabolic Research Laboratories support was provided by the following core facilities: Disease Model Core, Histology Core, Imaging Core and Core Biochemical Assay Laboratory (supported by the MRC, grant no